Caffeine shampoo — popularised by brands such as Alpecin — has attracted significant consumer interest as a hair loss treatment. The marketing is compelling, but understanding what caffeine actually does to hair follicles and whether a shampoo is an effective delivery mechanism requires looking at the evidence more carefully.
The biological rationale for caffeine and hair comes from laboratory research showing that caffeine inhibits the enzyme phosphodiesterase, which leads to increased levels of cAMP in hair follicle cells. Elevated cAMP promotes cell growth and has been shown in vitro (in lab-grown follicle cells) to counteract the inhibitory effect of DHT on follicle growth cycles. These are genuinely interesting findings that provide a plausible mechanism.
The challenge is translating laboratory cell culture findings to clinical reality. Hair follicles sit deep in the scalp, and for caffeine to reach them in sufficient concentrations, it must penetrate the skin barrier effectively. Shampoo typically contacts the scalp for a very short period before being rinsed off — raising questions about how much caffeine is actually absorbed and retained.
The clinical evidence for caffeine shampoo producing measurable improvements in hair density in humans with androgenetic alopecia is modest at best. The studies that exist are often small, industry-funded, and measure surrogate outcomes rather than the outcomes patients care about — maintained hairline and sustained density.
The honest summary: caffeine shampoo is unlikely to cause harm and may provide a modest benefit as part of a comprehensive approach. It should not be relied upon as a primary treatment for androgenetic hair loss.
Related reading
